Cloud Health Euroventures
Venture capitalNewark · Pre-Seed–Series A · 21 people tracked
Investment thesis
Cloud Health Euroventures targets early-stage digital health and life sciences companies in Southeastern Europe that demonstrate capital efficiency and clear market adoption pathways. The fund emphasizes strong founding teams, scalable technology solutions, and digital-first innovation particularly in AI-powered healthcare, telemedicine, remote patient monitoring, and provider solutions. The investment thesis centers on identifying startups addressing healthcare utilization, cost efficiency, and patient care challenges while leveraging Southeastern European talent and providing strategic connections to Western healthcare markets.
Source: firm website, verified Jul 21, 2026.
Team · 21 people
from the firm's websiteR&D engineering professional with 17+ years of experience in academic research, technology commercialization, organizational development, and operations.
Serial biotech entrepreneur with over 15 years of investment and operational experience in life sciences startups.
Innovation consultant and CEO of Newzip specializing in technology and product development, with prior leadership experience at Keller Williams in innovation strategy.
Imperial College London professor and global expert in asthma, allergy, and respiratory medicine whose research has advanced understanding of asthma phenotypes and precision medicine.
Physician and MedTech advisor with 10+ years in hospital leadership and consulting; specialist in pneumology with expertise in AI and imaging, founder of EvoMed Consulting.
Biomedical scientist and Marie Curie awardee with 15+ years of innovation and leadership in precision medicine, medical diagnostics, and drug development across healthcare and academic sectors.
Corporate attorney with 20 years specializing in mergers and acquisitions, private equity, and strategic investments across healthcare, life sciences, real estate, and manufacturing sectors.
Serial founder with 20+ years in food, beverage, and hospitality technology; built and scaled six F&B brands across the UK and Europe, now advises growth-stage founders.
Healthcare operations and finance leader with expertise in mergers, acquisitions, and strategic growth across the healthcare sector, focused on aligning clinical excellence with financial performance.
Harvard Medical School professor, world-renowned geneticist, molecular engineer, and synthetic biology pioneer whose research has advanced biotechnology and medicine.
Expert in intellectual property, antitrust, and regulatory economics with previous engineering experience at Lockheed Martin and a Ph.D. from Harvard Business School.
Bioinformatics engineer with dual master's degrees and Chevening Scholar; co-founder of Tisalytics Bio developing AI-driven solutions in genomics, with pharma and biotech experience.
Healthcare operations leader with expertise in scaling clinical services and digital health innovation; former executive at a major California women's health group with eight-figure exit, co-founder of OmniHelio and MD Learning.
Enterprise technology executive with 30 years of IT strategy, sales, and M&A experience; former IBM leader with global perspective on emerging markets, focused on enterprise technology investments.
Project manager and analyst with five years of experience in biotech and digital health startups.
Product and technology leader with 15+ years driving innovation at the intersection of technology and AI; held senior roles at Apple including contributions to Apple Music launch and AI-driven workflow development.
Former IBM Fellow and Vice President of Data & AI with over 70 patents and decades of expertise in how enterprises harness data, cloud, and artificial intelligence technologies.
Investment advisor and ecosystem builder with expertise in venture capital, scientific due diligence, and healthcare innovation; trained as a physical chemist with experience across European accelerators and venture programs.
Technology leader with 25+ years in software engineering and product strategy, former CEO of ZIRA with expertise in telecom and enterprise innovation.
Technology expert with nearly 40 years in Silicon Valley, driving innovation in software engineering, AI, and product strategy across startups and Fortune 500 companies.
Finance professional with 15+ years of financial management experience across diverse industries, including digital health and biotech sectors, holding degrees from Rider University.
Frequently asked questions
- What stage does Cloud Health Euroventures invest at?
- Cloud Health Euroventures invests at the Pre-Seed, Seed, Series A stages.
- What is Cloud Health Euroventures's typical check size?
- Cloud Health Euroventures typically writes checks of $100K – $1M.
- What sectors does Cloud Health Euroventures focus on?
- Cloud Health Euroventures focuses on AI & Machine Learning, Biotech, Digital Health, SaaS.
- Where is Cloud Health Euroventures located?
- Cloud Health Euroventures is headquartered in Newark, RS.
- Does Cloud Health Euroventures lead rounds?
- Cloud Health Euroventures typically participates in rounds rather than leading them.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
Hyderabad Angels is a collective of experienced entrepreneurs, industrialists, and family offices founded in 2010 that provides mentorship, capital, and network access to early-stage founders. The organization invests in seed and pre-seed companies across sector-agnostic technology, healthcare, consumer, and other emerging sectors.
An early-stage venture capital firm investing in technology founders building solutions across multiple sectors.
Avalon Ventures is a venture capital firm focused on seed and early-stage investments in life science and information technology companies. The firm is led by former entrepreneurs who are committed to supporting passionate founders pursuing disruptive ideas.